Europe Anaphylaxis Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others) and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)
Market Introduction
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response. It is a severe, life threatening allergic reaction marked by indications such as swallowing and breathing difficulties, skin itching, and lowering blood pressure.
Thus, the rising incidence of anaphylaxis is expected to create a significant demand for anaphylaxis treatment in the coming years, which is further anticipated to drive the anaphylaxis treatment market.
The rapid growth of COVID-19 cases in Europe has had a major impact on the European economy. Spain, Italy, Germany, France, and the United Kingdom are among the European countries most affected. In collaboration with the European Academy of Allergy and Clinical Immunology (EAACI), it published “Allergy and Its Impact on Asthma (ARIA).” Experts in their respective fields recently published a compendium with answers to 150 commonly asked questions about COVID-19 and allergic diseases. Furthermore, readers can put further questions regarding this “living” compendium electronically to the authors, and their answers will be available through a new category in the journal’s webpage. Besides, EAACI, in collaboration with ARIA, has provided recommendations on operational plans and practical procedures for ensuring optimal standards in the daily clinical care of patients with allergic diseases whilst ensuring the safety of patients and healthcare workers. Therefore, growing awareness of allergy linked to COVID-19 in Europe during is likely to demand for anaphyalaxis treatment and supply in COVID Pandemic, hence it can boost the growth of the anaphylaxis treatment market.
Get more information on this report :
Market Overview and Dynamics
The Anaphylaxis treatment market in Europe is expected to grow from US$ 534.0 million in 2021 to US$ 987.2 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. Cases of allergies have been observed after the COVID-19 vaccination. Along with this, patients with an anaphylaxis history should carry an epinephrine autoinjector to bring it to their vaccination appointment. Along with this initiative, COVID-19 vaccination places should have at least three doses of epinephrine ready at all times, along with the capability to replace supplies after epinephrine is administered to a patient. Nevertheless, anaphylaxis as an AEFI is uncommon, occurring at a rate of less than 1 per million doses for most vaccines. These factors present an opportunity for the growth of the anaphylaxis treatment market in the current COVID-19 scenario.
Key Market Segments
In terms of medication type, the epinephrine segment accounted for the largest share of the Europe anaphylaxis treatment market in 2020. In terms of route of administration, the parenteral segment accounted for the largest share of the Europe anaphylaxis treatment market in 2020. In terms of allergy type, the food allergy segment accounted for the largest share of the Europe anaphylaxis treatment market in 2020. In terms of distribution channel, the retail pharmacies segment held a larger market share of the anaphylaxis treatment market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the anaphylaxis treatment market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Amneal Pharmaceuticals Inc., Mylan N.V., BIOPROJET, Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck and Co., Inc., Teva Pharmaceutical Industries Ltd., and ALK-ABELLó.
Reasons to buy report
- To understand the Europe anaphylaxis treatment market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe anaphylaxis treatment market
- Efficiently plan M&A and partnership deals in Europe Anaphylaxis treatment market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe Anaphylaxis treatment market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.
EUROPE ANAPHYLAXIS TREATMENT MARKET SEGMENTATION
By Medication Type
- Epinephrine
- Antihistamines
- Steroids
- Beta-Agonist
- Others
By Route of Administration
- Parenteral
- Oral
- Others
By Allergy Type
- Food Allergy
- Medications
- Insect Stings
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Companies Mentioned
- Amneal Pharmaceuticals Inc.
- Mylan N.V.
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
- BIOPROJET
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Anaphylaxis Treatment Market – By Medication Type
1.3.2 Anaphylaxis Treatment Market – By Route of Administration
1.3.3 Anaphylaxis Treatment Market – By Allergy Type
1.3.4 Anaphylaxis Treatment Market – By Distribution Channel
1.3.5 Europe Anaphylaxis Treatment Market – By Country
2. Europe Anaphylaxis Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Anaphylaxis Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anaphylaxis Treatment Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe Anaphylaxis Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Anaphylaxis
5.1.2 Recent Approvals for Epinephrine
5.2 Market Restraints
5.2.1 Poor Access to Epinephrine Auto-Injectors in Low-Income Countries
5.3 Market Opportunities
5.3.1 Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
5.4 Future Trends
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis
6. Anaphylaxis Treatment Market – Europe Analysis
6.1 Europe Anaphylaxis Treatment Market Revenue Forecasts and Analysis
7. Europe Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Medication Type
7.1 Overview
7.2 Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
7.3 Epinephrine
7.3.1 Overview
7.3.2 Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Antihistamines
7.4.1 Overview
7.4.2 Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Steroids
7.5.1 Overview
7.5.2 Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Beta-Agonist
7.6.1 Overview
7.6.2 Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8. Anaphylaxis Treatment Market Analysis – By Route of Administration
8.1 Overview
8.2 Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Allergy Type
9.1 Overview
9.2 Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)
9.3 Food Allergy
9.3.1 Overview
9.3.2 Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Medications
9.4.1 Overview
9.4.2 Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Insect Stings
9.5.1 Overview
9.5.2 Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Anaphylaxis Treatment Market Analysis and Forecasts to 2028– By Distribution Channel
10.1 Overview
10.2 Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
10.3 Retail Sales
10.3.1 Overview
10.3.2 Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
11. Anaphylaxis Treatment Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 Europe: Anaphylaxis Treatment Market
11.1.1 Overview
11.1.2 Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.1.2.1 Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 Germany: Anaphylaxis Treatment Market, by Medication Type 2019–2028 (USD Million)
11.1.2.1.3 Germany: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.1.4 Germany: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.1.5 Germany: anaphylaxis treatment Market, by Allergy Type 2019–2028 (USD Million)
11.1.2.1.6 Germany: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.1.2.2 UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 UK: Anaphylaxis Treatment Market, Medication Type, 2019–2028 (USD Million)
11.1.2.2.3 UK: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.2.4 UK: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.2.5 UK: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)
11.1.2.2.6 UK: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.1.2.3 France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 France: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.3.3 France: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.3.4 France: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.3.5 France: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)
11.1.2.3.6 France: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.1.2.4 Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.1 Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.2 Italy: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.4.3 Italy: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.4.4 Italy: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.4.5 Italy: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.4.6 Italy: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.5 Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.5.1 Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.5.2 Spain: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.5.3 Spain: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.5.4 Spain: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.5.5 Spain: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.5.6 Spain: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.6 Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.6.1 Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.6.2 Rest of Europe: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.6.3 Rest of Europe: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.6.4 Rest of Europe: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.6.5 Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.6.6 Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Europe Anaphylaxis Treatment Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.2 ALK-Abelló A/S
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Amneal Pharmaceuticals, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 BIOPROJET
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 MYLAN N.V.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Germany: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)
Table 6. UK: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 7. UK: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 10. UK: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)
Table 11. France: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 12. France: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 13. France: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. France: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 15. France Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 17. Italy: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 18. Italy: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 19. Italy: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 20. Italy: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 21. Spain: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 22. Spain: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 23. Spain: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 24. Spain: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 25. Spain: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of Europe: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Europe: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Europe: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 31. Organic Developments Done by Companies
Table 32. Inorganic Developments Done by Companies
Table 33. Glossary of Terms, Anaphylaxis Treatment Market
LIST OF FIGURES
Figure 1. Anaphylaxis Treatment Market Segmentation
Figure 2. Europe Anaphylaxis Treatment Market Overview
Figure 3. Epinephrine Segment Held Largest Share of Medication Type in Anaphylaxis Treatment Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Anaphylaxis Treatment Market - Europe PEST Analysis
Figure 6. Anaphylaxis Treatment Market Impact Analysis of Driver and Restraints
Figure 7. Europe Anaphylaxis Treatment Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
Figure 9. Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)
Figure 15. Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)
Figure 19. Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
Figure 24. Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 27. Europe: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 28. Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 29. Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in European Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)
- Amneal Pharmaceuticals Inc.
- Mylan N.V.
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
- BIOPROJET
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe anaphylaxis treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe anaphylaxis treatment market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the anaphylaxis treatment market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution